Supernus (SUPN) Capital Expenditures (2022 - 2026)
Supernus Pharmaceuticals (SUPN) posted Capital Expenditures of $230,000 for Q3 2026, up 78.3% from $129,000 a year earlier but down 59.5% from the prior quarter.
Powered by 
Analysis
Supernus (SUPN) Capital Expenditures (2022 - 2026) Analysis & Trends
For the trailing twelve months through Sep 30, 2026, Capital Expenditures at Supernus Pharmaceuticals was $1.23 million, up 9.0% year-over-year; for FY2025, it came in at $1.34 million, up 84.6% from FY2024.
- Annual Capital Expenditures has increased for three consecutive years, though with a five-year compound annual growth rate of -17.3% (FY2020 to FY2025).
- In prior years, Supernus Pharmaceuticals' Capital Expenditures was $725,000 in FY2024 (+31.6%), $551,000 in FY2023 (+33.7%) and $412,000 in FY2022.
- Quarterly Capital Expenditures has run from a low of -$576,000 in Q2 2022 to a high of $851,000 in Q1 2022 over five years.
- On a year-over-year basis, Capital Expenditures increased in five of the last six quarters, with growth averaging 135.1%.
- The strongest year-over-year quarter for Capital Expenditures in the past five years was Q2 2025, with growth of 610.9%; the weakest was Q1 2023, with a decline of 67.3%.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 3.18 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 1.36 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 301.00 Mn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 1.04 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | -3.30 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 587.00 Mn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 237.00 Mn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 573.00 Mn |
| 10 | Supernus | 3.39 Bn | 2.50 Bn | 305.00 Mn | 14.00 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 14.00 Mn |
| Jun 30, 2026 | 7.00 Mn |
| Mar 31, 2026 | 20.00 Mn |
| Dec 31, 2025 | 24.00 Mn |
| Sep 30, 2025 | 20.00 Mn |
| Jun 30, 2025 | 17.00 Mn |
| Mar 31, 2025 | 5.00 Mn |
| Dec 31, 2024 | 16.00 Mn |
| Sep 30, 2024 | 7.00 Mn |
| Jun 30, 2024 | 4.00 Mn |
| Mar 31, 2024 | 2.00 Mn |
| Dec 31, 2023 | 12.00 Mn |
| Sep 30, 2023 | -2.00 Mn |
| Jun 30, 2023 | -1.00 Mn |
| Mar 31, 2023 | -1.00 Mn |
| Dec 31, 2022 | 9.00 Mn |
| Sep 30, 2022 | -2.00 Mn |
API Access
Supernus Capital Expenditures API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=capital-expenditures&ticker=SUPN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "capital-expenditures", "ticker": "SUPN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=capital-expenditures&ticker=SUPN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();